Launches·October 20, 2026 at 2:10 AM EDT·1 source
AstraZeneca Partners With Oracle to Refine Clinical Research With AI
AZN -0.6%ORCL
AZN · last 30 trading days+4.6% since the news
News
What happened
- AstraZeneca is teaming up with Oracle to refine clinical research using artificial intelligence.
- The partnership is the latest AI collaboration in the pharmaceutical industry.
Why it matters
The collaboration highlights continued adoption of AI in pharmaceutical research and is relevant to healthcare and technology professionals tracking clinical-development tools and partnerships.
Deal terms
stake
Oracle → AstraZeneca
Value
—
Read more on YouBank
The Newsroom, ranked for your desk
About ninety free sources every ten minutes, one story per event, read for you: bankers, investors, operators and students each get their own desk. Free to start.
Timeline
- EarlierOct 19Stock Market Today: Stock Futures Rebound After Friday's Tech Selloff
- First reported by The Wall Street JournalOct 20AstraZeneca Partners With Oracle to Refine Clinical Research With AI
Who is involved
stake inAstraZeneca Partners With Oracle to Refine Clinical Research …AstraZenecaAZN · targetOracleORCL · buyer
CompanyThe deal
Sources (1)
- The Wall Street JournalOct 20AstraZeneca Partners With Oracle to Refine Clinical Research With AI
Related
- 5h · STAT+: At ESMO, AstraZeneca’s cancer pursuits get a showcase
- 7h · #ESMO26: AstraZeneca's Tagrisso-Orpathys combo may extend Tagrisso's life in lung cancer
- Yesterday · #ESMO26: AstraZeneca eyes Keytruda's Padcev spot; Lilly's ADC takes on Elahere; Nubeqa targets earlier prostate cancer
- Yesterday · Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer
- Oct 23 · Turmoil hits AI buildout as neoclouds face pressure, credit risks mount and Solidigm pulls IPO
- Oct 19 · Stock Market Today: Stock Futures Rebound After Friday's Tech Selloff
Read more on YouBank
The Newsroom, ranked for your desk
About ninety free sources every ten minutes, one story per event, read for you: bankers, investors, operators and students each get their own desk. Free to start.
- Why it matters to youEvery story matched to your watchlist, your contacts and your pipeline.
- Follow developing storiesAn alert, and a push, the moment a story you follow moves.
- Your briefing, read aloudA few minutes each morning with a chapter per story.
- Brief modeSwipe through the day, a 20-second card each.